713
Views
14
CrossRef citations to date
0
Altmetric
Review

Extra-pulmonary manifestations of COPD and the role of pulmonary rehabilitation: a symptom-centered approach

ORCID Icon, &
Pages 131-142 | Received 31 Jul 2020, Accepted 19 Nov 2020, Published online: 10 Dec 2020

References

  • The Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD 2020. ( accessed 2020 July 15) Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf
  • Agusti A. The path to personalised medicine in COPD. Thorax. 2014;69(9):857–864.
  • Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183(9):1129–1137.
  • Dourado VZ, Tanni SE, Vale SA, et al. Systemic manifestations in chronic obstructive pulmonary disease. J Bras Pneumol. 2006;32(2):161–171.
  • Vanfleteren LE, Spruit MA, Wouters EF, et al. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med. 2016;4(11):911–924.
  • Polastri M. Physiotherapeutic regimen in patients with chronic obstructive pulmonary disease: from the intensive care unit to home-based rehabilitation. Int J Ther Rehabil. 2020;27(1):1–5.
  • Miravitlles M, Worth H, JJS C, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(1):122.
  • Spruit MA, Vercoulen JH, Sprangers MA, et al. Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med. 2017;5(7):542–544.
  • Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67.
  • Tsiligianni I, Kocks JW. Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. NPJ Prim Care Respir Med. 2020;30(1):1–9.
  • Landt E, Çolak Y, Lange P, et al. Chronic cough in individuals with COPD: a population-based cohort study. Chest. 2020;157(6):1446–1454.
  • Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272.
  • Jones P, Brusselle G, Dal Negro R, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57–66.
  • Koo H-K, Park S-W, Park J-W, et al. Chronic cough as a novel phenotype of chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis. 2018;13:1793.
  • Miravitlles M, Izquierdo JL, Esquinas C, et al. The variability of respiratory symptoms and associated factors in COPD. Respir Med. 2017;129:165–172.
  • Roberts MH, Mapel DW, Hartry A, et al. Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc. 2013;10(4):290–298.
  • Lewko A, Bidgood P, Jewell A. et al. A comprehensive literature review of COPD-related fatigue. Curr Respir Med Rev. 2012;8(5):370–382.
  • Lee AL, Harrison SL, Goldstein RS, et al. Pain and its clinical associations in individuals with COPD: a systematic review. Chest. 2015;147(5):1246–1258.
  • van Isselt E, Groenewegen-Sipkema KH, Spruit-van Eijk M, et al. Pain in patients with COPD: a systematic review and meta-analysis. BMJ Open. 2014;4:e005898.
  • Kentson M, Tödt K, Skargren E, et al. Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD. Ther Adv Respir Dis. 2016;10(5):410–424.
  • Stridsman C, Skär L, Hedman L, et al. Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD. 2015;12(2):199–206.
  • Kapella MC, Larson JL, Patel MK, et al. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res. 2006;55(1):10–17.
  • Deslee G, Burgel P-R, Escamilla R, et al. Impact of current cough on health-related quality of life in patients with COPD. Int J Chronic Obstr Pulm Dis. 2016;11:2091.
  • Burgel P-R, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009;135(4):975–982.
  • Satia I, Badri H, Lahousse L, et al. Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018. J Thorac Dis. 2018;10(Suppl 25):S2992.
  • Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11–S18.
  • Budhiraja R, Siddiqi TA, Quan SF. Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med. 2015;11(3):259–270.
  • Chang C-H, Chuang L-P, Lin S-W, et al. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2016;16(1):118.
  • Ierodiakonou D, Bouloukaki I, Kampouraki M, et al.Subjective sleep quality is associated with disease status in COPD patients. The cross-sectional Greek UNLOCK study. Sleep Breathing. 2020;24(4):1599–1605
  • Lohne V, Heer HCD, Andersen M, et al. Qualitative study of pain of patients with chronic obstructive pulmonary disease. Heart Lung. 2010;39(3):226–234.
  • Shah A, Ayas N, Tan W-C, et al. Sleep quality and nocturnal symptoms in a community-based COPD cohort. COPD. 2020;17(1):40–48.
  • Lan -C-C, Huang H-C, Yang M-C, et al. Pulmonary rehabilitation improves subjective sleep quality in COPD. Respir Care. 2014;59(10):1569–1576.
  • Dodd J, Getov S, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922.
  • Greenlund KJ, Liu Y, Deokar AJ, et al. Association of chronic obstructive pulmonary disease with increased confusion or memory loss and functional limitations among adults in 21 states, 2011 behavioral risk factor surveillance system. Prev Chron Dis. 2016;13:150428.
  • Incalzi RA, Chiappini F, Fuso L, et al. Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med. 1998;92(3):527–533.
  • Shum J, Poureslami I, Wiebe D. et al. Bridging the gap: key informants’ perspectives on patient barriers in asthma and COPD self-management and possible solutions. Can J Respir Crit Care Sleep Med. 2020;4(2):106–114.
  • Shorofsky M, Bourbeau J, Kimoff J, et al. Impaired sleep quality in COPD is associated with exacerbations: the cancold cohort study. Chest. 2019;156(5):852–863.
  • von Leupoldt A, Farre N. The load of dyspnoea on brain and legs. Eur Respir J. 2020;56(2):2001096.
  • Cleutjens FA, Franssen FM, Spruit MA, et al. Domain-specific cognitive impairment in patients with COPD and control subjects. Int J Chronic Obstr Pulm Dis. 2017;12:1–11.
  • Ouellette DR, Lavoie KL. Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD. Int J Chronic Obstr Pulm Dis. 2017;12:639–650.
  • Martinez CH, Richardson CR, Han MK, et al. Chronic obstructive pulmonary disease, cognitive impairment, and development of disability: the health and retirement study. Ann Am Thorac Soc. 2014;11(9):1362–1370.
  • Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142(6):1516–1523.
  • Michalovic E, Jensen D, Dandurand RJ. et al. Description of participation in daily and social activities for individuals with COPD. COPD: J Chron Obstr Pulm Dis. 2020;17(5):543–556
  • Chen S, Small M, Lindner L, et al. Symptomatic burden of COPD for patients receiving dual or triple therapy. Int J Chron Obstr Pulm Dis. 2018;13:1365–1376.
  • Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64.
  • McDonald VM, Osadnik CR, Gibson PG. Treatable traits in acute exacerbations of chronic airway diseases. Chron Respir Dis. 2019;16:1–16.
  • Van’t Hul AJ, Koolen EH, Antons JC, et al. Treatable traits qualifying for non-pharmacological interventions in COPD patients upon first referral to a pulmonologist: the COPD sTRAITosphere. ERJ Open Res. 2020;6:00438.
  • Spruit MA, Wouters EF. Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases. Respirology. 2019;24(9):838–843.
  • Anzueto A, Miravitlles M. Pathophysiology of dyspnea in COPD. Postgrad Med. 2017;129(3):366–374.
  • Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452.
  • O’Donnell DE, Milne KM, James MD, et al. Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther. 2020;1–20.
  • Hanania NA, O’Donnell DE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstr Pulm Dis. 2019;14:1127.
  • Ramon MA, Ter Riet G, Carsin A-E, et al. The dyspnoea–inactivity vicious circle in COPD: development and external validation of a conceptual model. Eur Respir J. 2018;52:3.
  • Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342.
  • Debigaré R, Maltais F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol. 2008;105(2):751–753.
  • Nici L. Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med. 2000;21(4):693–704.
  • O’Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol. 2008;105(2):753–755.
  • Miravitlles M, Ferrer J, Baró E, et al. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013;107(12):1977–1985.
  • Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440.
  • McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2.DOI: 10.1002/14651858.CD003793.pub3.
  • Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(13):1329–1335.
  • Wadell K, Webb KA, Preston ME, et al. Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. COPD. 2013;10(4):425–435.
  • Herigstad M, Faull OK, Hayen A, et al. Treating breathlessness via the brain: changes in brain activity over a course of pulmonary rehabilitation. Eur Respir J. 2017;50(3):1701029.
  • Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. Eur Respir Rev. 2013;22:178–186.
  • Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5):4S–42S.
  • Gosselink R, De Vos J, Van Den Heuvel S, et al. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37(2):416–425.
  • Langer D, Ciavaglia C, Faisal A, et al. Inspiratory muscle training reduces diaphragm activation and dyspnea during exercise in COPD. J Appl Physiol. 2018;125(2):381–392.
  • Ambrosino N. Inspiratory muscle training in stable COPD patients: enough is enough? Eur Respir J. 2018;51:1702285.
  • Polkey MI, Ambrosino N. Inspiratory muscle training in COPD: can data finally beat emotion? Thorax. 2018;73(10):900–901.
  • Beaumont M, Mialon P, Le Ber C, et al. Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial. Eur Respir J. 2018;51(1):1701107.
  • Schultz K, Jelusic D, Wittmann M, et al. Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial. Eur Respir J. 2018;51(1):1702000.
  • Goërtz YM, Spruit MA, Van ‘T Hul AJ, et al. Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation. Ther Adv Respir Dis. 2019;13:1753466619878128.
  • Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud. 1997;34(1):44–53.
  • Small S, Lamb M. Fatigue in chronic illness: the experience of individuals with chronic obstructive pulmonary disease and with asthma. J Adv Nurs. 1999;30(2):469–478.
  • Van Herck M, Antons J, Vercoulen JH, et al. Pulmonary rehabilitation reduces subjective fatigue in COPD: a responder analysis. J Clin Med. 2019;8(8):1264.
  • Gruet M. Fatigue in chronic respiratory diseases: theoretical framework and implications for real-life performance and rehabilitation. Front Physiol. 2018;9:1285.
  • Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153(3):976–980.
  • Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity, ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992;146:935.
  • Kouijzer M, Brusse-Keizer M, Bode C. COPD-related fatigue: impact on daily life and treatment opportunities from the patient’s perspective. Respir Med. 2018;141:47–51.
  • Baghai-Ravary R, Quint JK, Goldring JJ, et al. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med. 2009;103(2):216–223.
  • Paddison JS, Effing TW, Quinn S, et al. Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J. 2013;41(3):565–570.
  • Rebelo P, Oliveira A, Andrade L, et al. Minimal clinically important differences for patient-reported outcome measures of fatigue in patients with COPD following pulmonary rehabilitation. Chest. 2020;158(2):550–561.
  • Peters JB, Heijdra YF, Daudey L, et al. Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Couns. 2011;85(2):281–285.
  • Lewko A, Bidgood PL, Jewell A, et al. Evaluation of multidimensional COPD-related subjective fatigue following a pulmonary rehabilitation programme. Respir Med. 2014;108(1):95–102.
  • Peters JB, Boer LM, Molema J, et al. Integral health status-based cluster analysis in moderate–severe COPD patients identifies three clinical phenotypes: relevant for treatment as usual and pulmonary rehabilitation. Int J Behav Med. 2017;24(4):571–583.
  • Choate R, Pasquale CB, Parada NA, et al. The burden of cough and phlegm in people with COPD: A COPD patient-powered research network study. Chronic Obstr Pulm Dis. 2020;7(1):49.
  • Smith J, Woodcock A. Cough and its importance in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):305.
  • Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med. 2011;105(8):1118–1128.
  • Crooks MG, Brown T, Morice AH. Is cough important in acute exacerbations of COPD? Resp Physiol Neurobiol. 2018;257:30–35.
  • Ramos FL, Krahnke JS, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chronic Obstructive Pulm Dis. 2014;9:139.
  • Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. Int J Chronic Obstr Pulm Dis. 2015;10:1935.
  • Burgel P-R, Wedzicha JA. Chronic cough in chronic obstructive pulmonary disease: time for listening? Am J Respir Crit Care Med. 2013;187(9):902–904.
  • Lindberg A, Sawalha S, Hedman L, et al. Subjects with COPD and productive cough have an increased risk for exacerbations and death. Respir Med. 2015;109(1):88–95.
  • Kim V, Zhao H, Regan E, et al. The St. George’s Respiratory Questionnaire definition of chronic bronchitis may be a better predictor of COPD exacerbations compared with the classic definition. Chest. 2019;156(4):685–695.
  • Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153(5):1530–1535.
  • Cook N, Gey J, Oezel B, et al. Impact of cough and mucus on COPD patients: primary insights from an exploratory study with an online patient community. Int J Chronic Obstructive Pulm Dis. 2019;14:1365.
  • Sobrinho GC, James T, Pond Z, et al. Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD. Eur Respir J. 2015;46:PA546.
  • McCarroll ML, Pohle-Krauza RJ, Volsko TA, et al. Use of the breathlessness, cough, and sputum scale (BCSS©) in pulmonary rehabilitation. Open Respir Med J. 2013;7:1.
  • Houben-Wilke S, Janssen DJ, Franssen FM, et al. Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores. Health Qual Life Outcomes. 2018;16(1):205.
  • Rebelo P, Oliveira A, Paixão C, et al. Minimal clinically important differences for patient-reported outcome measures of cough and sputum in patients with COPD. Int J Chronic Obstr Pulm Dis. 2020;15:201.
  • Jr F O, Dolovich M, Montgomery J, et al. Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. Amer Rev Respir Dis. 1979;120(4):739–745.
  • Shen M, Li Y, Ding X, et al. Effect of active cycle of breathing techniques in patients with chronic obstructive pulmonary disease: a systematic review of intervention. Eur J Phys Rehabil Med. 2020.
  • Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349.
  • Atlantis E, Fahey P, Cochrane B, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–777.
  • Yohannes AM, Junkes-Cunha M, Smith J, et al. Management of dyspnea and anxiety in chronic obstructive pulmonary disease: a critical review. J Am Med Dir Assoc. 2017;18(12):1096. e1-1096. e17.
  • Mikkelsen RL, Middelboe T, Pisinger C, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65–70.
  • Dueñas-Espín I, Demeyer H, Gimeno-Santos E, et al. Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. int J Chronic Obstr Pulm Dis. 2016;11:1287.
  • Fan VS, Meek PM. Anxiety, depression, and cognitive impairment in patients with chronic respiratory disease. Clin Chest Med. 2014;35(2):399–409.
  • Gordon CS, Waller JW, Cook RM, et al. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis. Chest. 2019;156(1):80–91.
  • Williams MT, Johnston KN, Paquet C. Cognitive behavioral therapy for people with chronic obstructive pulmonary disease: rapid review. Int J Chronic Obstr Pulm Dis. 2020;15:903.
  • Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–1982.
  • HajGhanbari B, Holsti L, Road JD, et al. Pain in people with chronic obstructive pulmonary disease (COPD). Respir Med. 2012;106(7):998–1005.
  • Christensen VL, Holm AM, Kongerud J, et al. Occurrence, characteristics, and predictors of pain in patients with chronic obstructive pulmonary disease. Pain Manage Nurs. 2016;17(2):107–118.
  • Harrison SL, Lee AL, Elliott-Button HL, et al. The role of pain in pulmonary rehabilitation: a qualitative study. Int J Chronic Obstr Pulm Dis. 2017;12:3289.
  • Lewthwaite H, Williams G, Baldock KL, et al. Systematic review of pain in clinical practice guidelines for management of COPD: a case for including chronic pain? Healthcare. 2019;7(1):15.
  • Lee AL, Goldstein RS, Brooks D. Chronic pain in people with chronic obstructive pulmonary disease: prevalence, clinical and psychological implications. Chron Obstructive Pulm Dis. 2017;4(3):194.
  • Bentsen SB, Rustøen T, Miaskowski C. Differences in subjective and objective respiratory parameters in patients with chronic obstructive pulmonary disease with and without pain. Int J Chronic Obstr Pulm Dis. 2012;7:137.
  • de Miguel-díez J, López-de-Andrés A, Hernandez-Barrera V, et al. Prevalence of pain in COPD patients and associated factors. Clin J Pain. 2018;34(9):787–794.
  • HajGhanbari B, Garland SJ, Road JD, et al. Pain and physical performance in people with COPD. Respir Med. 2013;107(11):1692–1699.
  • Lee AL, Harrison SL, Goldstein RS, et al. An exploration of pain experiences and their meaning in people with chronic obstructive pulmonary disease. Physiother Theory Pract. 2018;34(10):765–772.
  • Lee AL, Butler SJ, Varadi RG, et al. The impact of pulmonary rehabilitation on chronic pain in people with COPD. COPD. 2020;17(2):165–174.
  • Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain: why and when. Best Pract Res Clin Rheumatol. 2015;29(1):120–130.
  • Vanfleteren LE, Beghe B, Andersson A, et al. Multimorbidity in COPD, does sleep matter? Eur J Internal Med. 2020;73:7–15.
  • Chokroverty S Overview of normal sleep. In: Sleep disorders medicine. New York: Springer; 2017. p. p. 5–27.
  • McNicholas WT, Hansson D, Schiza S, et al. Sleep in chronic respiratory disease: COPD and hypoventilation disorders. Eur Respir Rev. 2019;28(153):190064.
  • Ding B, Small M, Bergström G, et al. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD. Int J Chronic Obstr Pulm Dis. 2017;12:589.
  • Akinci B, Aslan GK, Kiyan E. Sleep quality and quality of life in patients with moderate to very severe chronic obstructive pulmonary disease. Clin Respir J. 2018;12(4):1739–1746.
  • Shackell BS, Jones RC, Harding G, et al. ‘Am I going to see the next morning?’A qualitative study of patients’ perspectives of sleep in COPD. Primary Care Respir J. 2007;16(6):378–383.
  • Nunes DM, Mota RMS, de Pontes Neto OL, et al. Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung. 2009;187(3):159–163.
  • Agusti A, Hedner J, Marin J, et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(121):183–194.
  • Scharf SM, Maimon N, Simon-Tuval T, et al. Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis. 2011;6:1.
  • Chen R, Tian J, Zhou L, et al. The relationship between sleep quality and functional exercise capacity in COPD. Clin Respir J. 2016;10(4):477–485.
  • Kapella MC, Herdegen JJ, Perlis ML, et al. Cognitive behavioral therapy for insomnia comorbid with COPD is feasible with preliminary evidence of positive sleep and fatigue effects. Int J Chronic Obstr Pulm Dis. 2011;6:625.
  • Şahin ZA, Dayapoğlu N. Effect of progressive relaxation exercises on fatigue and sleep quality in patients with chronic obstructive lung disease (COPD). Complement Ther Clin Pract. 2015;21(4):277–281.
  • Yilmaz CK, Kapucu S. The effect of progressive relaxation exercises on fatigue and sleep quality in individuals with COPD. Holist Nurs Pract. 2017;31(6):369–377.
  • Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD. 2013;10(2):156–163.
  • Oh H-W, Kim S-H, Kim K-U. The effects a respiration rehabilitation program on IADL, satisfaction with leisure, and quality of sleep of patients with chronic obstructive pulmonary disease. J Phys Ther Sci. 2016;28(12):3357–3360.
  • Nobeschi L, Zangirolami-Raimundo J, Cordoni PK, et al. Evaluation of sleep quality and daytime somnolence in patients with chronic obstructive pulmonary disease in pulmonary rehabilitation. BMC Pulm Med. 2020;20(1):14.
  • McDonnell LM, Hogg L, McDonnell L, et al. Pulmonary rehabilitation and sleep quality: a before and after controlled study of patients with chronic obstructive pulmonary disease. NPJ Prim Care Respir Med. 2014;24(1):1–5.
  • Thapamagar S, Ellstrom K, Anholm J, et al. Impact of pulmonary rehabilitation on sleep in COPD patients as measured by actigraphy. Am J Respir Crit Care Med. 2019;199:A5733.
  • Zanchet RC, CAdA V, Lima T. Influence of pulmonary rehabilitation on the sleep patterns of patients with chronic obstructive pulmonary disease. Jornal Brasileiro De Pneumologia. 2004;30:5.
  • Cox NS, Pepin V, Burge AT, et al. Pulmonary rehabilitation does not improve objective measures of sleep quality in people with chronic obstructive pulmonary disease. COPD. 2019;16(1):25–29.
  • Andrianopoulos V, Gloeckl R, Vogiatzis I, et al. Cognitive impairment in COPD: should cognitive evaluation be part of respiratory assessment? Breathe. 2017;13(1):e1–e9.
  • van Beers M, Janssen DJ, Gosker HR, et al. Cognitive impairment in chronic obstructive pulmonary disease: disease burden, determinants and possible future interventions. Expert Rev Respir Med. 2018;12(12):1061–1074.
  • Yohannes AM, Chen W, Moga AM, et al. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 2017;18(5):451. e1-451. e11.
  • Baird C, Lovell J, Johnson M, et al. The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: a systematic review. Respir Med. 2017;129:130–139.
  • Park SK. Trajectories of change in cognitive function in people with chronic obstructive pulmonary disease. J Clin Nurs. 2018;27(7–8):1529–1542.
  • Aquino G, Iuliano E, Di Cagno A, et al. Effects of combined training vs aerobic training on cognitive functions in COPD: a randomized controlled trial. Int J Chronic Obstr Pulm Dis. 2016;11:711.
  • Desveaux L, Harrison SL, Gagnon J-F, et al. Effects of exercise training on cognition in chronic obstructive pulmonary disease: a systematic review. Respir Med. 2018;139:110–116.
  • Incalzi RA, Corsonello A, Trojano L, et al. Cognitive training is ineffective in hypoxemic COPD: a six-month randomized controlled trial. Rejuvenation Res. 2008;11(1):239–250.
  • Spruit MA, Pitta F, Garvey C, et al. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J. 2014;43(5):1326–1337.
  • Troosters T, Blondeel A, Janssens W, et al. The past, present and future of pulmonary rehabilitation. Respirology. 2019;24(9):830–837.
  • Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4–e27.
  • Spruit MA, Augustin IM, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J. 2015;46(6):1625–1635.
  • Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology. 2017;22(4):800–819.
  • Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. Thorax. 2013;68(Suppl 2):ii1–ii30.
  • Augustin IM, Spruit MA, Franssen FM, et al. Incorporating comprehensive assessment parameters to better characterize and plan rehabilitation for persons with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2020;S1525-8610(20): 30429–1.
  • Cook NS, Kostikas K, Gruenberger J-B, et al. Patients’ perspectives on COPD: findings from a social media listening study. ERJ Open Res. 2019;5:00128–2018.
  • Zhang Y, Morgan RL, Alonso-Coello P, et al. A systematic review of how patients value COPD outcomes. Eur Respir J. 2018;52:1800222.
  • Kuyucu T, Güçlü SZ, Saylan B, et al. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study. Tuberk Toraks. 2011;59(4):328.
  • van der Molen T, Miravitlles M, Kocks JW. COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis. 2013;8:461.
  • Rochester CL, Spanevello A. Heterogeneity of pulmonary rehabilitation: like apples and oranges–both healthy fruit. Eur Respir J. 2014;43:1223–1226.
  • The lancet respiratory medicine. Maximising the data potential in COPD research. Lancet Respir Med. 2017;5(7):535.
  • Souto-Miranda S, Marques A. Triangulated perspectives on outcomes of pulmonary rehabilitation in patients with COPD: a qualitative study to inform a core outcome set. Clin Rehabil. 2019;33(4):805–814.
  • Williamson PR, Altman DG, Bagley H, et al. The COMET handbook: version 1.0. Trials. 2017;18(3):280.
  • Kirkham JJ, Gorst S, Altman DG, et al. Core outcome set–STAndards for reporting: the COS-STAR statement. PLoS Med. 2016;13(10):e1002148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.